Log in to save to my catalogue

Therapy with oncolytic viruses: progress and challenges

Therapy with oncolytic viruses: progress and challenges

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2765071492

Therapy with oncolytic viruses: progress and challenges

About this item

Full title

Therapy with oncolytic viruses: progress and challenges

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Clinical oncology, 2023-03, Vol.20 (3), p.160-177

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the benefits of selective replication in tumour cells, delivery of multiple eukaryotic transgene payloads, induction of immunogenic cell death and promotion of antitumour immunity, and a tolerable safety profile that largely does not overlap with that of other cancer th...

Alternative Titles

Full title

Therapy with oncolytic viruses: progress and challenges

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2765071492

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2765071492

Other Identifiers

ISSN

1759-4774

E-ISSN

1759-4782

DOI

10.1038/s41571-022-00719-w

How to access this item